Tag: Christina Coughlin
Avacta appoints Dr Christina Coughlin as Non-Executive Director
Dr. Coughlin is the Chief Executive Officer of CytoImmune Therapeutics, Inc., a clinical stage biotechnology company, focused on the development and commercialisation of novel cancer immunotherapy products